PORFINIO ROMERO: Open Payments
NPI 1396047957 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,145 in 44 payments from 15 companies in 2025. Trend: 2023 $683 · 2024 $869 · 2025 $1,145
Food & beverage: $1,145
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $297 |
| Genentech USA, Inc. | 4 | $118 |
| Regeneron Healthcare Solutions, Inc. | 5 | $117 |
| GENZYME CORPORATION | 4 | $113 |
| Novartis Pharmaceuticals Corporation | 3 | $103 |
| Viatris Specialty LLC | 3 | $69 |
| Ionis Pharmaceuticals, Inc. | 2 | $68 |
| Incyte Corporation | 2 | $51 |
| GlaxoSmithKline, LLC. | 2 | $49 |
| X4 Pharmaceuticals, Inc. | 1 | $38 |
Products named: DUPIXENT, TEZSPIRE, Xolair, FASENRA, YUPELRI, Rhapsido, OPZELURA, NUCALA.
Industry payments across NM — which companies pay providers there.
